LUCD   $1.4  3.56% Market Closed

Lucid Diagnostics Inc
Last Events:

2023-08-06 Signal in Stochastic changed from bullish weakening to bullish recovery. The stochastic indicator is in overbought territory and it heading north. These factors indicate that the upside potential still holds even though the market is overbought. Last signal: main and signal line crossing.

2023-08-06 Signal in MACD changed from bearish weakening to bullish. Oscillator MACD is in the positive territory it's higher than the signal line and it crossed the zero line from the bottom. These factors mean that there is probably a growing trend. Last signal: up-crossing the middle level.

2023-08-06 Trend Power changed from strong to .

2023-08-05 Signal in RSI changed from bullish weakening to bullish recovery. RSI indicator is in the upper part of the neutral territory and it heading north. These factors indicate that positive dynamics is recovering. Last signal: exit from the overbought zone.

2023-08-05 Signal in EMA100 changed from bearish reversal to bullish reversal. The price is trying to cross up the moving average line If the intersection will be successful, then an upside trend can be formed.

2023-08-05 Signal in EMA50 changed from bearish reversal to bullish reversal. The price is trying to cross up the moving average line If the intersection will be successful, then an upside trend can be formed.

2023-08-04 Signal in Stochastic changed from bullish to bullish weakening. The stochastic indicator is in overbought territory and it falls. These factors indicate that perhaps the upside trend is coming to an end. Last signal: main and signal line crossing.

2023-08-04 Signal in RSI changed from bullish to bullish weakening. RSI indicator is in the upper part of the neutral territory and it heading south. These factors indicate that the downside trend is forming. Last signal: exit from the overbought zone.


Current temperature: 2.47
ST: 0, Cor:

Analyst Recommendations:
Number of estimates 5
Target Price Mean 4.16
Mean unverified/preliminary 4.16 / 4.16
Target Price Low / High 2.50 / 9.00
Median / STD DEV 3.00 / 2.76
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Sell
rsi None ActivelyBuy Sell
macd Sell None None
stoch Sell None None
ma20 Sell Sell None
ma50 Sell None None
ma100 Sell Sell None
Candlestick PatternNov. 10, 2023 Hammer - is a candlestick that consists of a small body near the high with a little or no upper shadow and a long lower tail. Considered to be a bullish pattern during a downtrend.
ISIN US54948X1090
ceo Dr. Lishan Aklog M.D.
Website https://www.luciddx.com
Lucid Diagnostics Inc., a commercial-stage medical diagnostics technology company, focuses on patients with gastroesophageal reflux disease who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma in the United States. The company's flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. Lucid Diagnostics Inc. was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.